Hormone Therapy

Top Story

No difference in cognitive impairment seen in men on testosterone treatment

February 24, 2017

Read the Perspective from Alexander Kutikov, MD

One year of testosterone treatment did not improve memory or other cognitive functions compared with placebo among older men with low testosterone and age-associated memory impairment, according to study findings published in JAMA.

“Aging is associated with declines in some cognitive functions, including verbal and visual memory, executive function, and spatial ability,” Susan M. Resnick, PhD, from the laboratory of behavioral neuroscience at the NIH’s National Institute on Aging, and colleagues wrote. “Aging in men is also associated with a reduction in serum testosterone, raising the possibility that reduced circulating testosterone concentration may contribute to age-related cognitive decline.”

In the Journals Plus

GH therapy improves linear growth, adult height in Prader-Willi syndrome

February 23, 2017
Prepubertal and adolescent children with Prader-Willi syndrome treated with recombinant human growth hormone therapy before the onset of puberty saw increased linear…
In the Journals Plus

Testosterone replacement therapy may lower CV risk in androgen deficiency

February 23, 2017
The risk for adverse cardiovascular outcomes, including stroke and acute myocardial infarction, may be decreased with the use of testosterone replacement therapy in men…
In the Journals Plus

Oral contraception improves HDL function in overweight, obesity, PCOS

February 22, 2017
HDL cholesterol function may be improved with the use of oral contraceptives for 16 weeks in women with overweight or obesity and polycystic ovary syndrome. “The…
CME CNE CE CE

Diabetic Retinopathy: Preferred Practice Patterns in Screening and Management

This activity is supported by an educational grant from Regeneron.

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence…
More »
Video
Meeting News Coverage

VIDEO: Testosterone Trials results announcement met with anticipation

April 7, 2016
More »
Featured
ObesityWeek

ObesityWeek

CME

Improving Bone Strength and Reducing Fracture Risk in Osteoporosis

This activity is supported by an educational grant from Merck & Co., Inc.

Osteoporosis is characterized by low bone mass and microarchitectural deterioration of bone tissue leading to reduced…
More »
In the JournalsPerspective

No difference in cognitive impairment seen in men on testosterone treatment

February 24, 2017
One year of testosterone treatment did not improve memory or other cognitive functions compared with placebo among older men with low testosterone…

In the Journals Plus

GH therapy improves linear growth, adult height in Prader-Willi syndrome

February 23, 2017
Prepubertal and adolescent children with Prader-Willi syndrome treated with recombinant human growth hormone therapy before the onset of puberty saw…

In the Journals Plus

Testosterone replacement therapy may lower CV risk in androgen deficiency

February 23, 2017
The risk for adverse cardiovascular outcomes, including stroke and acute myocardial infarction, may be decreased with the use of testosterone…

In the Journals Plus

Oral contraception improves HDL function in overweight, obesity, PCOS

February 22, 2017
HDL cholesterol function may be improved with the use of oral contraceptives for 16 weeks in women with overweight or obesity and polycystic ovary…

In the Journals

Testosterone treatment improves bone density, strength in older men

February 22, 2017
One year of testosterone treatment significantly increased volumetric bone mineral density and estimated bone strength in men aged 65 years and…

In the JournalsPerspective

Increase in noncalcified plaque associated with testosterone treatment in older men

February 21, 2017
Testosterone treatment in older men was linked to a significantly greater increase in coronary artery noncalcified plaque volume, according to a new…

In the Journals

Anti-Müllerian hormone trajectories associated with CVD

February 21, 2017
Decline in anti-Müllerian hormone was associated with increased risk for CVD, according to recently published findings. Recent studies had…

In the Journals

Testosterone treatment increases hemoglobin levels, improves anemia in older men

February 21, 2017
Men aged 65 years and older with unexplained anemia may benefit from measurement and treatment of testosterone levels, according to data published in…

In the Journals PlusPerspective

Satisfaction, acceptability high with vaginal estradiol softgel capsules

February 17, 2017
Postmenopausal women with vulvar and vaginal atrophy reported high satisfaction and acceptability with vaginal estradiol softgel capsules compared…

In the Journals Plus

Previous cancer affects future cancer incidence, mortality risk with pediatric GH therapy

February 17, 2017
In patients with previous cancers treated with recombinant human growth hormone therapy as children, researchers observed increased risks for both…

More Headlines »
Advertisement
Advertisement